Ads
related to: keytruda- What Is KEYTRUDA?
Learn About What KEYTRUDA Is & How
It May Help Eligible Patients.
- Side Effects
Learn About Possible Side Effects
at the Official Patient Site.
- Treatment Options
Learn About Treatment
Options With KEYTRUDA.
- Get Financial Help
Find Assistance and Payment
Information for Eligible Patients.
- Taking KEYTRUDA?
Learn What to Expect When
Taking KEYTRUDA.
- Clinical Trial Results
See Clinical Trial Results
at the Official Site.
- What Is KEYTRUDA?
Search results
Merck to acquire eye drug company EyeBio for up to $3 billion
WHTC 1450 Holland· 18 hours ago(Reuters) - Merck said on Wednesday it would acquire eye disease drug developer EyeBio for up to $3...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 5 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
Zacks via Yahoo Finance· 3 days agoData from an earlier cut-off date shows that treatment with Merus' (MRUS) combination therapy...
Billionaire Ken Griffin Is Buying These Dividend Stocks Hand Over Fist. Should You?
Motley Fool via Yahoo Finance· 6 days agoThe big drugmaker's forward dividend yield stands at nearly 2.4%. The stock is on a roll so far in...
No Memes, Ma'am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.
InvestorPlace· 19 hours agoNot long ago, GameStop (NYSE:GME) stock soared and then tanked on the meme-stock waves. A company...
Exclusive | Merck Nears $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 1 day agoSuch an acquisition would steer a company known for its cancer immunotherapy, Keytruda, into the...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 4 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
South African Voters Set to Snub Mandela’s Party - What’s News - WSJ Podcasts
The Wall Street Journal· 19 hours agoPeter Granitz: Chicago has an idea to save its dying downtown, give developers millions of dollars to attract tenants. Plus, Democrats have a plan to recapture the House, a $100 million in ads ...
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 2 days agoGrowth is set to be driven by sales of Opdivo and Keytruda in the first-line metastatic setting,...
Why This Top 4% Biotech Just Catapulted To A Record High
Investor's Business Daily· 5 days agoThe Netherlands-based biotech paired its drug, petosemtamab, with Merck's (MRK) cancer blockbuster, ...
Ads
related to: keytruda